Does Rallies track congressional trades in MET?

Yes. Rallies tracks politician and congressional stock disclosures for MET, including reported purchases, sales, dates, owners, and trade amounts when available.

Is MET research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MET. It does not provide personalized investment advice.

MET (MetLife) Stock Analysis - Politician Trades

MetLife (MET) is a publicly traded Financial Services sector company. As of May 20, 2026, MET trades at $82.40 with a market cap of $52.38B and a P/E ratio of 15.88. MET moved +1.77% today. Year to date, MET is +0.93%; over the trailing twelve months it is +0.25%. Its 52-week range spans $65.21 to $89.05. Analyst consensus is strong buy with an average price target of $93.20. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded MET stock?

Recent politician trading activity in MET includes disclosures from Ritchie Torres, Sheldon Whitehouse, Thomas R. Carper, Sheldon Whitehouse, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

MET Key Metrics

Key financial metrics for MET
Metric	Value
Price	$82.40
Market Cap	$52.38B
P/E Ratio	15.88
EPS	$5.20
Dividend Yield	0.59%
52-Week High	$89.05
52-Week Low	$65.21
Volume	2.09M
Avg Volume	0
Revenue (TTM)	$77.59B
Net Income	$3.62B
Gross Margin	0.00%

Congressional Trades in MET

Ritchie Torres sale MET on Jul 11, 2025 (amount: $15.00K).
Sheldon Whitehouse sale (full) MET on Nov 19, 2024 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (partial) MET on Jan 17, 2024 (amount: $15.00K) for Spouse.
Sheldon Whitehouse sale (full) MET on Sep 20, 2023 (amount: $15.00K) for Self.
Thomas R. Carper sale (partial) MET on Jan 18, 2022 (amount: $15.00K) for Spouse.

Latest MET News

MetLife Commits $170M to Revamp Water Tower Place, Eyes Medical Office Conversion — Apr 27, 2026
MetLife jumps as life insurers catch a bid; strong 2025 results keep bulls in control — Apr 8, 2026
MetLife jumps as yields slide and quarter-end risk appetite returns — Mar 31, 2026
MetLife drops 3% as yields slide and analyst caution weighs on life insurers — Mar 27, 2026
MetLife Adds Ex-Marsh CEO Dan Glaser, Russell Investments’ Michelle Seitz to Board — Feb 24, 2026

MET Analyst Consensus

11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.20.

Common questions about MET

Which politicians traded MET stock?: Recent politician trading activity in MET includes disclosures from Ritchie Torres, Sheldon Whitehouse, Thomas R. Carper, Sheldon Whitehouse, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in MET?: Yes. Rallies tracks politician and congressional stock disclosures for MET, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MET research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MET. It does not provide personalized investment advice.